Makoto Kuboki

Summary

Affiliation: Kawasaki Medical School
Country: Japan

Publications

  1. ncbi Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients
    Makoto Kuboki
    Division of Hepatology, Kawasaki Medical School, Okayama, Japan
    J Gastroenterol Hepatol 22:645-52. 2007
  2. ncbi Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701 0192, Japan
    Cardiovasc Intervent Radiol 29:1111-3. 2006
  3. ncbi Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan
    J Gastroenterol Hepatol 24:223-7. 2009
  4. ncbi CO2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701 0192, Japan
    J Clin Ultrasound 35:78-81. 2007
  5. ncbi Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701 0192, Japan
    J Vasc Interv Radiol 17:723-6. 2006
  6. ncbi Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study
    Kerji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan
    Hepatogastroenterology 54:985-9. 2007
  7. ncbi [Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon therapy for chronic hepatitis C]
    Fumi Suganami
    Division of Hepatology, Department of Internal Medicine, Kawasaki Medical School
    Nihon Shokakibyo Gakkai Zasshi 104:809-14. 2007
  8. ncbi Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Okayama, Japan
    Hepatogastroenterology 53:651-4. 2006
  9. ncbi [Pyogenic liver abscess complicated by gastric fistula and bacterial meningitis]
    Yasuyuki Tomiyama
    Division of Hepatology, Department of Medicine, Kawasaki Medical School
    Nihon Shokakibyo Gakkai Zasshi 104:1512-8. 2007
  10. ncbi Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Okayama, Japan
    Dig Dis Sci 51:352-8. 2006

Collaborators

Detail Information

Publications15

  1. ncbi Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients
    Makoto Kuboki
    Division of Hepatology, Kawasaki Medical School, Okayama, Japan
    J Gastroenterol Hepatol 22:645-52. 2007
    ..The aim of this study was to evaluate this combination in treatment-naïve patients and in non-responders or relapsers to interferon monotherapy...
  2. ncbi Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701 0192, Japan
    Cardiovasc Intervent Radiol 29:1111-3. 2006
    ..By concomitant performance of transcatheter arterial chemoembolization with radiofrequency ablation, extensive necrosis was obtained and adequate tumor volume reduction achieved with only one treatment session...
  3. ncbi Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan
    J Gastroenterol Hepatol 24:223-7. 2009
    ..We evaluated the therapeutic efficacy and safety of these two procedures for the treatment of small HCC measuring < or = 2 cm in diameter...
  4. ncbi CO2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701 0192, Japan
    J Clin Ultrasound 35:78-81. 2007
    ..The patient had no serious adverse effects and has shown no recurrence during 35 months of follow-up...
  5. ncbi Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701 0192, Japan
    J Vasc Interv Radiol 17:723-6. 2006
    ..By concomitant application of these two techniques, complete tumor necrosis was achieved without the need to perform additional ablation...
  6. ncbi Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study
    Kerji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan
    Hepatogastroenterology 54:985-9. 2007
    ..We evaluated the clinical effect and safety of these two procedures for the treatment of small HCCs measuring 2cm or less in diameter...
  7. ncbi [Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon therapy for chronic hepatitis C]
    Fumi Suganami
    Division of Hepatology, Department of Internal Medicine, Kawasaki Medical School
    Nihon Shokakibyo Gakkai Zasshi 104:809-14. 2007
    ....
  8. ncbi Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Okayama, Japan
    Hepatogastroenterology 53:651-4. 2006
    ..To evaluate the initial therapeutic effect and safety of radiofrequency ablation (RFA) and percutaneous microwave coagulation therapy (PMCT) for the treatment of small hepatocellular carcinomas (HCCs)...
  9. ncbi [Pyogenic liver abscess complicated by gastric fistula and bacterial meningitis]
    Yasuyuki Tomiyama
    Division of Hepatology, Department of Medicine, Kawasaki Medical School
    Nihon Shokakibyo Gakkai Zasshi 104:1512-8. 2007
    ..Hepatic and gastric resections were performed because of the possibility of biliary cystadenocarcinoma and gastric invasion. Pathologically, a pyogenic liver abscess complicated by gastric fistula was diagnosed...
  10. ncbi Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Okayama, Japan
    Dig Dis Sci 51:352-8. 2006
    ..31 for death (P = 0.04). These results suggest that the combination of EVL plus PSE can prevent the recurrence of varices, progression to variceal bleeding, and death in cirrhosis patients with esophageal varices and thrombocytopenia...
  11. ncbi Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan
    Hepatogastroenterology 52:1344-6. 2005
    ....
  12. ncbi CT-guided percutaneous ethanol injection therapy for ultrasonically invisible hepatocellular carcinoma
    Kenji Ohmoto
    Division of Gastroenterology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701 0192, Japan
    Hepatogastroenterology 49:297-9. 2002
    ..In conclusion, computed tomography-guided percutaneous ethanol injection therapy was safe and accurately achieved the desired tumoricidal effect in a patient with ultrasonically invisible hepatocellular carcinoma...
  13. ncbi Percutaneous microwave coagulation therapy for superficial hepatocellular carcinoma on the surface of the liver
    Kenji Ohmoto
    Division of Gastroenterology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701 0192, Japan
    Hepatogastroenterology 50:1547-51. 2003
    ..This study was performed to evaluate the efficacy and safety of percutaneous microwave coagulation therapy for superficial hepatocellular carcinoma located on the surface of the liver...
  14. ncbi Combined intraarterial 5-fluorouracil and intramuscular interferon-alpha therapy for advanced hepatocellular carcinoma
    Kenji Ohmoto
    Division of Hepatology, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701 0192, Japan
    Hepatogastroenterology 50:1780-2. 2003
    ....
  15. ncbi Autoantibody in a patient with chronic hepatitis C virus infection showing complete remission after interferon therapy
    Yoshihiro Akashi
    Department of Internal Medicine, Kinashi Ohbayashi Hospital, Kagawa, Japan
    J Gastroenterol Hepatol 17:925-8. 2002
    ..To our knowledge, this is the first reported hepatitis C patient showing anti-RNP antibody and anti-SSB antibody, having complete remission after interferon therapy...